Elevance Health, Inc. Quarterly Amortization of Intangible Assets in USD from Q1 2010 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
The aggregate expense charged against earnings to allocate the cost of intangible assets (nonphysical assets not used in production) in a systematic and rational manner to the periods expected to benefit from such assets. As a noncash expense, this element is added back to net income when calculating cash provided by or used in operations using the indirect method.
Summary
Elevance Health, Inc. quarterly/annual Amortization of Intangible Assets history and growth rate from Q1 2010 to Q3 2024.
  • Elevance Health, Inc. Amortization of Intangible Assets for the quarter ending September 30, 2024 was $122M, a 42.5% decline year-over-year.
  • Elevance Health, Inc. Amortization of Intangible Assets for the twelve months ending September 30, 2024 was $617M, a 32.6% decline year-over-year.
  • Elevance Health, Inc. annual Amortization of Intangible Assets for 2023 was $885M, a 15.4% increase from 2022.
  • Elevance Health, Inc. annual Amortization of Intangible Assets for 2022 was $767M, a 73.9% increase from 2021.
  • Elevance Health, Inc. annual Amortization of Intangible Assets for 2021 was $441M, a 22.2% increase from 2020.
Amortization of Intangible Assets, Trailing 12 Months (USD)
Amortization of Intangible Assets, Quarterly (USD)
Amortization of Intangible Assets, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2024 $617M $122M -$90M -42.5% Jul 1, 2024 Sep 30, 2024 10-Q 2024-10-17
Q2 2024 $707M $162M -$59M -26.7% Apr 1, 2024 Jun 30, 2024 10-Q 2024-07-17
Q1 2024 $766M $116M -$119M -50.6% Jan 1, 2024 Mar 31, 2024 10-Q 2024-04-18
Q4 2023 $885M $217M -$30M -12.1% Oct 1, 2023 Dec 31, 2023 10-K 2024-02-21
Q3 2023 $915M $212M -$13M -5.78% Jul 1, 2023 Sep 30, 2023 10-Q 2024-10-17
Q2 2023 $928M $221M +$55M +33.1% Apr 1, 2023 Jun 30, 2023 10-Q 2024-07-17
Q1 2023 $873M $235M +$106M +82.2% Jan 1, 2023 Mar 31, 2023 10-Q 2024-04-18
Q4 2022 $767M $247M +$112M +83% Oct 1, 2022 Dec 31, 2022 10-K 2024-02-21
Q3 2022 $655M $225M +$89M +65.4% Jul 1, 2022 Sep 30, 2022 10-Q 2023-10-18
Q2 2022 $566M $166M +$76M +84.4% Apr 1, 2022 Jun 30, 2022 10-Q/A 2023-09-29
Q1 2022 $490M $129M +$49M +61.3% Jan 1, 2022 Mar 31, 2022 10-Q 2023-04-19
Q4 2021 $441M $135M +$43M +46.7% Oct 1, 2021 Dec 31, 2021 10-K 2024-02-21
Q3 2021 $398M $136M +$43M +46.2% Jul 1, 2021 Sep 30, 2021 10-Q 2022-10-19
Q2 2021 $355M $90M -$3M -3.23% Apr 1, 2021 Jun 30, 2021 10-Q 2022-07-20
Q1 2021 $358M $80M -$3M -3.61% Jan 1, 2021 Mar 31, 2021 10-Q 2022-04-20
Q4 2020 $361M $92M +$10M +12.2% Oct 1, 2020 Dec 31, 2020 10-Q 2023-10-18
Q3 2020 $351M $93M +$9M +10.7% Jul 1, 2020 Sep 30, 2020 10-Q 2021-10-20
Q2 2020 $342M $93M +$8M +9.41% Apr 1, 2020 Jun 30, 2020 10-Q 2021-07-21
Q1 2020 $334M $83M -$4M -4.6% Jan 1, 2020 Mar 31, 2020 10-Q 2021-04-21
Q4 2019 $338M $82M -$12M -12.8% Oct 1, 2019 Dec 31, 2019 10-K 2022-02-16
Q3 2019 $350M $84M -$7M -7.69% Jul 1, 2019 Sep 30, 2019 10-Q 2020-10-28
Q2 2019 $357M $85M -$8M -8.6% Apr 1, 2019 Jun 30, 2019 10-Q 2020-07-29
Q1 2019 $365M $87M +$7M +8.75% Jan 1, 2019 Mar 31, 2019 10-Q 2020-04-29
Q4 2018 $358M $94M +$49.4M +111% Oct 1, 2018 Dec 31, 2018 10-K 2021-02-18
Q3 2018 $309M $91M +$49M +117% Jul 1, 2018 Sep 30, 2018 10-Q 2019-10-23
Q2 2018 $260M $93M +$52.4M +129% Apr 1, 2018 Jun 30, 2018 10-Q 2019-07-24
Q1 2018 $207M $80M +$38.2M +91.4% Jan 1, 2018 Mar 31, 2018 10-Q 2019-04-24
Q4 2017 $169M $44.6M -$1.7M -3.67% Oct 1, 2017 Dec 31, 2017 10-K 2020-02-19
Q3 2017 $171M $42M -$5.4M -11.4% Jul 1, 2017 Sep 30, 2017 10-Q 2018-10-31
Q2 2017 $176M $40.6M -$7.3M -15.2% Apr 1, 2017 Jun 30, 2017 10-Q 2018-07-25
Q1 2017 $183M $41.8M -$8.6M -17.1% Jan 1, 2017 Mar 31, 2017 10-Q 2018-04-25
Q4 2016 $192M $46.3M -$11.2M -19.5% Oct 1, 2016 Dec 31, 2016 10-K 2019-02-20
Q3 2016 $203M $47.4M -$12.6M -21% Jul 1, 2016 Sep 30, 2016 10-Q 2017-10-25
Q2 2016 $216M $47.9M -$12.2M -20.3% Apr 1, 2016 Jun 30, 2016 10-Q 2017-07-26
Q1 2016 $228M $50.4M -$2.1M -4% Jan 1, 2016 Mar 31, 2016 10-Q 2017-04-26
Q4 2015 $230M $57.5M +$4.9M +9.32% Oct 1, 2015 Dec 31, 2015 10-K 2018-02-21
Q3 2015 $225M $60M -$300K -0.5% Jul 1, 2015 Sep 30, 2015 10-Q 2016-11-02
Q2 2015 $226M $60.1M +$6.1M +11.3% Apr 1, 2015 Jun 30, 2015 10-Q 2016-07-27
Q1 2015 $219M $52.5M -$1.5M -2.78% Jan 1, 2015 Mar 31, 2015 10-Q 2016-04-27
Q4 2014 $221M $52.6M -$7.1M -11.9% Oct 1, 2014 Dec 31, 2014 10-K 2017-02-22
Q3 2014 $228M $60.3M -$1M -1.63% Jul 1, 2014 Sep 30, 2014 10-Q 2015-10-28
Q2 2014 $229M $54M -$8.1M -13% Apr 1, 2014 Jun 30, 2014 10-Q 2015-07-29
Q1 2014 $237M $54M -$8.2M -13.2% Jan 1, 2014 Mar 31, 2014 10-Q 2015-04-29
Q4 2013 $245M $59.7M +$8.8M +17.3% Oct 1, 2013 Dec 31, 2013 10-K 2016-02-19
Q3 2013 $237M $61.3M -$2.6M -4.07% Jul 1, 2013 Sep 30, 2013 10-Q 2014-10-29
Q2 2013 $239M $62.1M +$2.6M +4.37% Apr 1, 2013 Jun 30, 2013 10-Q 2014-07-30
Q1 2013 $237M $62.2M +$3.5M +5.96% Jan 1, 2013 Mar 31, 2013 10-Q 2014-04-30
Q4 2012 $233M $50.9M -$13M -20.3% Oct 1, 2012 Dec 31, 2012 10-K 2015-02-24
Q3 2012 $246M $63.9M +$1.8M +2.9% Jul 1, 2012 Sep 30, 2012 10-Q 2013-10-23
Q2 2012 $244M $59.5M +$2.9M +5.12% Apr 1, 2012 Jun 30, 2012 10-Q 2013-07-24
Q1 2012 $241M $58.7M +$1.9M +3.35% Jan 1, 2012 Mar 31, 2012 10-Q 2013-04-24
Q4 2011 $239M $63.9M +$4.2M +7.04% Oct 1, 2011 Dec 31, 2011 10-K 2014-02-20
Q3 2011 $235M $62.1M +$1.7M +2.82% Jul 1, 2011 Sep 30, 2011 10-Q 2012-11-07
Q2 2011 $234M $56.6M -$4.3M -7.06% Apr 1, 2011 Jun 30, 2011 10-Q 2012-07-25
Q1 2011 $238M $56.8M -$3.9M -6.43% Jan 1, 2011 Mar 31, 2011 10-Q 2012-04-25
Q4 2010 $242M $59.7M Oct 1, 2010 Dec 31, 2010 10-K 2013-02-22
Q3 2010 $60.4M Jul 1, 2010 Sep 30, 2010 10-Q 2011-10-26
Q2 2010 $60.9M Apr 1, 2010 Jun 30, 2010 10-Q 2011-07-27
Q1 2010 $60.7M Jan 1, 2010 Mar 31, 2010 10-Q 2011-04-27
* An asterisk sign (*) next to the value indicates that the value is likely invalid.